Dongsheng Wang
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 1%
- Long-Term Effects of COVID-19
Papers in
- Oncology 8
- Colorectal Cancer Surgical Treatments 3
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Haiming Wei (3 shared papers)Xiaoling Xu (3 shared papers)Tiantian Li (2 shared papers)Binqing Fu (2 shared papers)Xiaohu Zheng (2 shared papers)Yonggang Zhou (2 shared papers)Yun Yang (1 shared paper)Xiao‐Hua Zhang (1 shared paper)
- Journals
- Medicine (2 papers)Frontiers in Oncology (2 papers)Journal of Autoimmunity (1 paper)Journal of Surgical Research (1 paper)Parasitology Research (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dongsheng Wang
34 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Infectious Diseases 1.6k
- Neurology 923
- Immunology 269
- Obstetrics and Gynecology 84
- Critical Care and Intensive Care Medicine 54
Countries citing papers authored by Dongsheng Wang
This map shows the geographic impact of Dongsheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongsheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongsheng Wang more than expected).
Fields of papers citing papers by Dongsheng Wang
This network shows the impact of papers produced by Dongsheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongsheng Wang. The network helps show where Dongsheng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongsheng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effective treatment of severe COVID-19 patients with tocilizumab Hit paper breakdown → | 2020 | 1874 |
| 2 | 2012 | 84 | |
| 3 | 2013 | 75 | |
| 4 | 2016 | 73 | |
| 5 | 2016 | 33 | |
| 6 | 2018 | 28 | |
| 7 | 2012 | 24 | |
| 8 | 2021 | 21 | |
| 9 | 2022 | 21 | |
| 10 | 2011 | 18 | |
| 11 | [Effects of actinomycetes agent on ginseng growth and rhizosphere soil microflora]. | 2013 | 16 |
| 12 | 2023 | 15 | |
| 13 | 2014 | 15 | |
| 14 | 2018 | 15 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 10 | |
| 17 | 2023 | 9 | |
| 18 | 2014 | 8 | |
| 19 | 2013 | 7 | |
| 20 | 2019 | 6 |
About Dongsheng Wang
Dongsheng Wang is a scholar working on Oncology, Infectious Diseases, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 35 papers that have together received 2.4k indexed citations. Recurring topics across this work include Radiomics and Machine Learning in Medical Imaging (4 papers), Long-Term Effects of COVID-19 (3 papers), Immune Cell Function and Interaction (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Magnetic confinement fusion research (3 papers), Gastric Cancer Management and Outcomes (3 papers), Fusion materials and technologies (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Neurology (923 citations), Immunology (269 citations), Obstetrics and Gynecology (84 citations) and Critical Care and Intensive Care Medicine (54 citations). Dongsheng Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Haiming Wei, Xiaoling Xu, Tiantian Li, Binqing Fu, Xiaohu Zheng, Yonggang Zhou, Yun Yang, Xiao‐Hua Zhang, Aijun Pan and Wei Sun. Their work appears in journals such as Medicine, Frontiers in Oncology, Journal of Autoimmunity, Journal of Surgical Research and Parasitology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.